CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: arenecarbaldehyde
Accession: CHEBI:33855
browse the term
Definition: Any aldehyde in which the carbonyl group is attached to an aromatic moiety.
Synonyms: related_synonym: Aromatic aldehyde; Formula=CHOR; SMILES=*C(=O)[H]; an aromatic aldehyde; arenecarbaldehydes; aryl aldehyde; aryl aldehydes
alt_id: CHEBI:13819; CHEBI:22621; CHEBI:2832; CHEBI:87908
xref: KEGG:C00193; MetaCyc:Aryl-Aldehyde
G
Ar
androgen receptor
multiple interactions
ISO
1-naphthaldehyde inhibits the reaction [Metribolone binds to AR protein]
CTD
PMID:3695475
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
increases metabolic processing
ISO
ALDH2 protein results in increased metabolism of 2,5-dihydroxybenzaldehyde
CTD
PMID:11744614
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Akr7a5
aldo-keto reductase family 7, member A5
increases reduction affects reduction
ISO EXP
AKR7A2 protein results in increased reduction of 2-nitrobenzaldehyde 2-nitrobenzaldehyde affects the reduction of AKR7A5 protein
CTD
PMID:10510318 PMID:12604212
NCBI chr 4:139,038,005...139,046,097
Ensembl chr 4:139,038,055...139,045,737
G
Ache
acetylcholinesterase
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of ACHE protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of ACHE protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Acta2
actin alpha 2, smooth muscle, aorta
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]
CTD
PMID:25582705
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Ager
advanced glycosylation end product-specific receptor
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of AGER protein] protocatechualdehyde inhibits the reaction [Bleomycin results in decreased expression of AGER protein]
CTD
PMID:17597607 PMID:25582705
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Cat
catalase
multiple interactions increases activity
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] protocatechualdehyde results in increased activity of CAT protein
CTD
PMID:29665407 PMID:29732668
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cdh1
cadherin 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]
CTD
PMID:25582705
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein] protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of FGF2 protein]
CTD
PMID:25582705
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of G6PD protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Glo1
glyoxalase 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [sodium arsenite results in increased activity of GLO1 protein]
CTD
PMID:29732668
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
G
Gsr
glutathione reductase
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of GSR protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hmgb1
high mobility group box 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of HMGB1 protein] protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of HMGB1 protein]
CTD
PMID:25582705
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
S100b
S100 protein, beta polypeptide, neural
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein]
CTD
PMID:17597607
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Smad2
SMAD family member 2
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein]
CTD
PMID:17597607
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
G
Smad3
SMAD family member 3
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein]
CTD
PMID:17597607
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Sod1
superoxide dismutase 1, soluble
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in increased activity of SOD1 protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of SOD1 protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of AGER protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of HMGB1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]
CTD
PMID:17597607 PMID:25582705
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Vim
vimentin
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]
CTD
PMID:25582705
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Ar
androgen receptor
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of AR protein
CTD
PMID:27633901
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of ESR1 protein
CTD
PMID:27633901
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of NR3C1 protein
CTD
PMID:27633901
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Pgr
progesterone receptor
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PGR protein
CTD
PMID:27633901
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein
CTD
PMID:27633901
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of THRB protein
CTD
PMID:27633901
NCBI chr14:4,429,599...4,810,538
Ensembl chr14:4,431,611...4,809,435
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
increases metabolic processing
ISO
ALDH2 protein results in increased metabolism of 3-hydroxybenzaldehyde
CTD
PMID:11744614
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
decreases activity multiple interactions increases oxidation
EXP ISO
4-(diethylamino)benzaldehyde results in decreased activity of ALDH1A1 protein 4-(diethylamino)benzaldehyde inhibits the reaction [ALDH1A1 protein results in decreased susceptibility to mafosfamide] ALDH1A1 protein results in increased oxidation of 4-(diethylamino)benzaldehyde
CTD
PMID:8662658 PMID:16316642 PMID:25512087
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Aldh1a2
aldehyde dehydrogenase family 1, subfamily A2
multiple interactions
ISO
4-(diethylamino)benzaldehyde binds to and results in decreased activity of ALDH1A2 protein
CTD
PMID:25512087
NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
multiple interactions
ISO
4-(diethylamino)benzaldehyde binds to and results in decreased activity of ALDH2 protein
CTD
PMID:25512087
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh3a1
aldehyde dehydrogenase family 3, subfamily A1
increases oxidation
ISO
ALDH3A1 protein results in increased oxidation of 4-(diethylamino)benzaldehyde
CTD
PMID:25512087
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
G
Akr1a1
aldo-keto reductase family 1, member A1
increases reduction
ISO
AKR1A1 protein results in increased reduction of 4-carboxybenzaladehyde
CTD
PMID:10510318
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr1a1
aldo-keto reductase family 1, member A1
increases reduction
ISO
AKR1A1 protein results in increased reduction of 4-nitrobenzaldehyde
CTD
PMID:10510318
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr1b1
aldo-keto reductase family 1 member B
increases reduction
ISO
AKR1B1 protein results in increased reduction of 4-nitrobenzaldehyde
CTD
PMID:10510318
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1b7
aldo-keto reductase family 1, member B7
increases metabolic processing
ISO
AKR1B15 protein results in increased metabolism of 4-nitrobenzaldehyde
CTD
PMID:21276782
NCBI chr 6:34,389,297...34,400,072
Ensembl chr 6:34,389,269...34,400,077
G
Akr7a5
aldo-keto reductase family 7, member A5
multiple interactions affects reduction
EXP
Ethacrynic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Indomethacin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Quercetin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Valproic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]
CTD
PMID:12604212
NCBI chr 4:139,038,005...139,046,097
Ensembl chr 4:139,038,055...139,045,737
G
Dhrs7
dehydrogenase/reductase 7
increases reduction
ISO
DHRS7 protein results in increased reduction of 4-nitrobenzaldehyde
CTD
PMID:24246760
NCBI chr12:72,697,127...72,711,678
Ensembl chr12:72,697,127...72,711,683
G
Dyrk2
dual-specificity tyrosine phosphorylation regulated kinase 2
multiple interactions
ISO
[Curcumin binds to 4-nitrobenzaldehyde] which results in decreased activity of DYRK2 protein
CTD
PMID:33617879
NCBI chr10:118,691,507...118,725,144
Ensembl chr10:118,691,508...118,706,114
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
EXP
NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 4-nitrobenzaldehyde]
CTD
PMID:20932822
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nphs1
nephrosis 1, nephrin
decreases expression
ISO
5-hydroxymethylfurfural co-treated with 3,4-dideoxyglucosone co-treated with Glyoxal co-treated with Methylglyoxal cotreated with 3-deoxyglucosone co-treated with Formaldehyde co-treated with acetaldehyde decreases expression of Nphs1 protein in kidneys
RGD
PMID:18346151
RGD:38599007
NCBI chr 7:30,157,259...30,188,048
Ensembl chr 7:30,157,740...30,186,648
G
Sult1a1
sulfotransferase family 1A, phenol-preferring, member 1
multiple interactions increases activity
ISO
[SULT1A1 protein co-treated with SULT1A2 protein] results in increased susceptibility to 5-hydroxymethylfurfural SULT1A2 protein results in increased activity of 5-hydroxymethylfurfural
CTD
PMID:22006426
NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604
G
Sult1d1
sulfotransferase family 1D, member 1
increases metabolic processing
EXP
SULT1D1 protein results in increased metabolism of 5-hydroxymethylfurfural
CTD
PMID:25370010
NCBI chr 5:87,702,509...87,716,865
Ensembl chr 5:87,702,504...87,716,886
G
Sult5a1
sulfotransferase family 5A, member 1
increases metabolic processing
EXP
SULT1A1 protein results in increased metabolism of 5-hydroxymethylfurfural
CTD
PMID:25370010
NCBI chr 8:123,869,582...123,885,170
Ensembl chr 8:123,866,931...123,885,054
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
increases oxidation increases metabolic processing
ISO EXP
ALDH1A1 protein results in increased oxidation of benzaldehyde ALDH1A1 protein results in increased metabolism of benzaldehyde
CTD
PMID:10998257 PMID:21256123
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
increases metabolic processing multiple interactions
ISO
ALDH2 protein results in increased metabolism of benzaldehyde benzaldehyde inhibits the reaction [4-dimethylaminocinnamaldehyde binds to ALDH2 protein]
CTD
PMID:10609638 PMID:11744614
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh3a1
aldehyde dehydrogenase family 3, subfamily A1
multiple interactions increases oxidation increases metabolic processing
ISO EXP
[ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde; [ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde; Cimetidine inhibits the reaction [ALDH3A1 protein results in increased oxidation of benzaldehyde] ALDH3A1 protein results in increased metabolism of benzaldehyde
CTD
PMID:10856427 PMID:21256123 PMID:21349255 PMID:23220590 PMID:25512087
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
affects binding
ISO
benzaldehyde binds to ALDH3B1 protein
CTD
PMID:20699116
NCBI chr19:3,963,491...3,980,898
Ensembl chr19:3,963,491...3,979,808
G
Ar
androgen receptor
multiple interactions
ISO
benzaldehyde inhibits the reaction [Metribolone binds to AR protein]
CTD
PMID:3695475
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
multiple interactions decreases activity increases chemical synthesis
ISO
[[benzaldehyde results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [benzaldehyde results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin CYP2A6 protein results in increased chemical synthesis of benzaldehyde
CTD
PMID:10616189 PMID:32496054
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Or8a1b
olfactory receptor family 8 subfamily A member 1B
multiple interactions
EXP
benzaldehyde binds to and results in increased activity of OR8A1 protein
CTD
PMID:11943806
NCBI chr 9:37,622,644...37,623,576
Ensembl chr 9:37,620,260...37,627,546
G
Slc2a1
solute carrier family 2 (facilitated glucose transporter), member 1
increases activity multiple interactions
EXP
benzaldehyde results in increased activity of SLC2A1 protein [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein
CTD
PMID:20955755
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
G
Aldh1a2
aldehyde dehydrogenase family 1, subfamily A2
decreases activity
ISO
Benzaldehydes results in decreased activity of ALDH1A2 protein
CTD
PMID:22079344
NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
decreases activity
ISO
Benzaldehydes results in decreased activity of ALDH2 protein
CTD
PMID:22079344
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
multiple interactions decreases activity
ISO
[[ethyl vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [ethyl vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin
CTD
PMID:32496054
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
EXP
[ethyl vanillin binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; ethyl vanillin binds to and results in increased activity of OR5D18 protein
CTD
PMID:15716417
NCBI chr 2:87,864,540...87,865,481
Ensembl chr 2:87,862,632...87,868,043
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
EXP
ethyl vanillin results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr11:73,158,315...73,191,194
Ensembl chr11:73,158,214...73,191,189
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
3-methylbenzaldehyde results in decreased activity of CYP2E1 protein
CTD
PMID:12791539
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
affects activity
ISO
3-methylbenzaldehyde affects the activity of CYP4B1 protein
CTD
PMID:12791539
NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
G
Kras
Kirsten rat sarcoma viral oncogene homolog
increases response to substance
ISO
KRAS protein mutant form results in increased susceptibility to oncrasin-1
CTD
PMID:21443218
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
G
Ugt1a10
UDP glycosyltransferase 1 family, polypeptide A10
increases glucuronidation
ISO
UGT1A10 protein results in increased glucuronidation of 2-vanillin
CTD
PMID:15117964
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of 2-vanillin
CTD
PMID:15117964
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity
ISO
4-anisaldehyde results in increased activity of TRPA1 protein
CTD
PMID:21591660
NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
G
Ahr
aryl-hydrocarbon receptor
multiple interactions
EXP
4-methylbenzaldehyde binds to and results in decreased activity of AHR protein
CTD
PMID:27633901
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Ar
androgen receptor
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of AR protein
CTD
PMID:27633901
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Esr2
estrogen receptor 2 (beta)
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of ESR2 protein
CTD
PMID:27633901
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Il1b
interleukin 1 beta
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IL1B protein]
CTD
PMID:27569861
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:27569861
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
CTD
PMID:27569861
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
CTD
PMID:27569861
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]
CTD
PMID:27569861
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:27569861
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:27569861
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Pgr
progesterone receptor
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of PGR protein
CTD
PMID:27633901
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein
CTD
PMID:27633901
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:27569861
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:27569861
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Tnf
tumor necrosis factor
multiple interactions
EXP
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:27569861
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Aicda
activation-induced cytidine deaminase
affects expression
EXP
o-Phthalaldehyde affects the expression of AICDA mRNA
CTD
PMID:22302311
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
G
Akr1c18
aldo-keto reductase family 1, member C18
affects expression
EXP
o-Phthalaldehyde affects the expression of AKR1C18 mRNA
CTD
PMID:22302311
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
G
Ccl6
C-C motif chemokine ligand 6
affects expression
EXP
o-Phthalaldehyde affects the expression of CCL6 mRNA
CTD
PMID:22302311
NCBI chr11:83,478,712...83,483,913
Ensembl chr11:83,478,708...83,483,913
G
Ccna2
cyclin A2
affects expression
EXP
o-Phthalaldehyde affects the expression of CCNA2 mRNA
CTD
PMID:22302311
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
G
Ccnb1
cyclin B1
affects expression
EXP
o-Phthalaldehyde affects the expression of CCNB1 mRNA
CTD
PMID:22302311
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
G
Ccne2
cyclin E2
affects expression
EXP
o-Phthalaldehyde affects the expression of CCNE2 mRNA
CTD
PMID:22302311
NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
G
Ccr4
C-C motif chemokine receptor 4
affects expression
EXP
o-Phthalaldehyde affects the expression of CCR4 mRNA
CTD
PMID:22302311
NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
G
Cd207
CD207 antigen
affects expression
EXP
o-Phthalaldehyde affects the expression of CD207 mRNA
CTD
PMID:22302311
NCBI chr 6:83,648,189...83,654,839
Ensembl chr 6:83,648,197...83,654,839
G
Cd5l
CD5 antigen-like
affects expression
EXP
o-Phthalaldehyde affects the expression of CD5L mRNA
CTD
PMID:22302311
NCBI chr 3:87,265,188...87,278,381
Ensembl chr 3:87,265,188...87,278,380
G
Cd83
CD83 antigen
affects expression
EXP
o-Phthalaldehyde affects the expression of CD83 mRNA
CTD
PMID:22302311
NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
G
Cdc20
cell division cycle 20
affects expression
EXP
o-Phthalaldehyde affects the expression of CDC20 mRNA
CTD
PMID:22302311
NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549
G
Cdc25c
cell division cycle 25C
affects expression
EXP
o-Phthalaldehyde affects the expression of CDC25C mRNA
CTD
PMID:22302311
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
G
Cdk1
cyclin dependent kinase 1
affects expression
EXP
o-Phthalaldehyde affects the expression of CDK1 mRNA
CTD
PMID:22302311
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
G
Clec7a
C-type lectin domain family 7, member a
affects expression
EXP
o-Phthalaldehyde affects the expression of CLEC7A mRNA
CTD
PMID:22302311
NCBI chr 6:129,438,554...129,449,748
Ensembl chr 6:129,438,554...129,449,742
G
Col8a1
collagen, type VIII, alpha 1
affects expression
EXP
o-Phthalaldehyde affects the expression of COL8A1 mRNA
CTD
PMID:22302311
NCBI chr16:57,444,619...57,575,100
Ensembl chr16:57,444,621...57,575,100
G
Cphx1
cytoplasmic polyadenylated homeobox 1
affects expression
EXP
o-Phthalaldehyde affects the expression of CPHX1 mRNA
CTD
PMID:22302311
NCBI chr14:25,941,983...25,956,798
Ensembl chr14:25,938,728...25,956,780
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
affects expression
EXP
o-Phthalaldehyde affects the expression of CTLA4 mRNA
CTD
PMID:22302311
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
EXP
o-Phthalaldehyde results in decreased expression of CYP1A1 mRNA
CTD
PMID:20112102
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
EXP
o-Phthalaldehyde results in decreased expression of CYP2E1 mRNA
CTD
PMID:20112102
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Dio1
deiodinase, iodothyronine, type I
decreases activity
ISO
o-Phthalaldehyde results in decreased activity of DIO1 protein
CTD
PMID:30561685
NCBI chr 4:107,148,662...107,164,365
Ensembl chr 4:107,148,662...107,164,366
G
Dio2
deiodinase, iodothyronine, type II
decreases activity
ISO
o-Phthalaldehyde results in decreased activity of DIO2 protein
CTD
PMID:30561685
NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812
G
Dio3
deiodinase, iodothyronine type III
decreases activity
ISO
o-Phthalaldehyde results in decreased activity of DIO3 protein
CTD
PMID:30561685
NCBI chr12:110,245,664...110,247,531
Ensembl chr12:110,245,502...110,247,531
G
E2f1
E2F transcription factor 1
affects expression
EXP
o-Phthalaldehyde affects the expression of E2F1 mRNA
CTD
PMID:22302311
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
Fabp7
fatty acid binding protein 7, brain
affects expression
EXP
o-Phthalaldehyde affects the expression of FABP7 mRNA
CTD
PMID:22302311
NCBI chr10:57,661,019...57,664,546
Ensembl chr10:57,660,977...57,664,546
G
Fxyd4
FXYD domain-containing ion transport regulator 4
affects expression
EXP
o-Phthalaldehyde affects the expression of FXYD4 mRNA
CTD
PMID:22302311
NCBI chr 6:117,910,519...117,914,668
Ensembl chr 6:117,910,520...117,914,653
G
Gzmb
granzyme B
affects expression
EXP
o-Phthalaldehyde affects the expression of GZMB mRNA
CTD
PMID:22302311
NCBI chr14:56,496,293...56,499,791
Ensembl chr14:56,496,295...56,499,717
G
Ifng
interferon gamma
increases expression
EXP
o-Phthalaldehyde results in increased expression of IFNG mRNA
CTD
PMID:21785612
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Iglv1
immunoglobulin lambda variable 1
affects expression
EXP
o-Phthalaldehyde affects the expression of IGLV1 mRNA
CTD
PMID:22302311
NCBI chr16:18,903,767...18,904,210
Ensembl chr16:18,903,767...18,904,250
G
Il10
interleukin 10
increases expression
EXP
o-Phthalaldehyde results in increased expression of IL10 mRNA
CTD
PMID:21785612
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12b
interleukin 12b
affects expression
EXP
o-Phthalaldehyde affects the expression of IL12B mRNA
CTD
PMID:22302311
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il13
interleukin 13
increases expression
EXP
o-Phthalaldehyde results in increased expression of IL13 mRNA
CTD
PMID:21785612
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il1b
interleukin 1 beta
increases expression
EXP
o-Phthalaldehyde results in increased expression of IL1B mRNA
CTD
PMID:21785612
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il21
interleukin 21
affects expression
EXP
o-Phthalaldehyde affects the expression of IL21 mRNA
CTD
PMID:22302311
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il2ra
interleukin 2 receptor, alpha chain
affects expression
EXP
o-Phthalaldehyde affects the expression of IL2RA mRNA
CTD
PMID:22302311
NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
G
Il4
interleukin 4
affects expression increases expression
EXP
o-Phthalaldehyde affects the expression of IL4 mRNA o-Phthalaldehyde results in increased expression of IL4 mRNA; o-Phthalaldehyde results in increased expression of IL4 protein
CTD
PMID:19110043 PMID:20176622 PMID:21785612 PMID:22302311
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il5
interleukin 5
increases expression
EXP
o-Phthalaldehyde results in increased expression of IL5 mRNA
CTD
PMID:19110043 PMID:21785612
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Itgav
integrin alpha V
affects expression
EXP
o-Phthalaldehyde affects the expression of ITGAV mRNA
CTD
PMID:22302311
NCBI chr 2:83,554,796...83,637,261
Ensembl chr 2:83,554,741...83,637,260
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
o-Phthalaldehyde inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr10:3,490,274...3,504,880
Ensembl chr10:3,490,240...3,504,877
G
Lgals7
lectin, galactose binding, soluble 7
affects expression
EXP
o-Phthalaldehyde affects the expression of LGALS7 mRNA
CTD
PMID:22302311
NCBI chr 7:28,563,258...28,565,711
Ensembl chr 7:28,563,278...28,565,709
G
Mcpt1
mast cell protease 1
affects expression
EXP
o-Phthalaldehyde affects the expression of MCPT1 mRNA
CTD
PMID:22302311
NCBI chr14:56,255,421...56,257,848
Ensembl chr14:56,255,428...56,257,841
G
Mcpt8
mast cell protease 8
affects expression
EXP
o-Phthalaldehyde affects the expression of MCPT8 mRNA
CTD
PMID:22302311
NCBI chr14:56,319,620...56,322,951
Ensembl chr14:56,319,623...56,322,730
G
Mki67
antigen identified by monoclonal antibody Ki 67
affects expression
EXP
o-Phthalaldehyde affects the expression of MKI67 mRNA
CTD
PMID:22302311
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Nts
neurotensin
affects expression
EXP
o-Phthalaldehyde affects the expression of NTS mRNA
CTD
PMID:22302311
NCBI chr10:102,317,617...102,326,294
Ensembl chr10:102,317,617...102,326,347
G
Thbs1
thrombospondin 1
affects expression
EXP
o-Phthalaldehyde affects the expression of THBS1 mRNA
CTD
PMID:22302311
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Thbs4
thrombospondin 4
affects expression
EXP
o-Phthalaldehyde affects the expression of THBS4 mRNA
CTD
PMID:22302311
NCBI chr13:92,888,094...92,931,326
Ensembl chr13:92,888,098...92,931,326
G
Timd2
T cell immunoglobulin and mucin domain containing 2
affects expression
EXP
o-Phthalaldehyde affects the expression of TIMD2 mRNA
CTD
PMID:22302311
NCBI chr11:46,559,787...46,597,934
Ensembl chr11:46,559,787...46,597,888
G
Timp1
tissue inhibitor of metalloproteinase 1
affects expression
EXP
o-Phthalaldehyde affects the expression of TIMP1 mRNA
CTD
PMID:22302311
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Tnf
tumor necrosis factor
increases expression
EXP
o-Phthalaldehyde results in increased expression of TNF mRNA
CTD
PMID:21785612
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trp53
transformation related protein 53
affects activity
ISO
o-Phthalaldehyde affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
affects expression
EXP
o-Phthalaldehyde affects the expression of TRPM6 mRNA
CTD
PMID:22302311
NCBI chr19:18,707,566...18,869,885
Ensembl chr19:18,727,347...18,869,875
G
Ache
acetylcholinesterase
multiple interactions
ISO
vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of ACHE protein]
CTD
PMID:33823243
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Akr1c21
aldo-keto reductase family 1, member C21
increases expression
ISO
vanillin results in increased expression of AKR1C2 mRNA
CTD
PMID:20491607
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Car1
carbonic anhydrase 1
decreases activity
ISO
vanillin results in decreased activity of CA1 protein
CTD
PMID:19231207
NCBI chr 3:14,831,274...14,873,425
Ensembl chr 3:14,831,276...14,873,428
G
Car2
carbonic anhydrase 2
decreases activity
ISO
vanillin results in decreased activity of CA2 protein
CTD
PMID:19231207
NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830
G
Casp3
caspase 3
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; vanillin inhibits the reaction [Methotrexate results in increased activity of CASP3 protein]
CTD
PMID:29216766
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Cat
catalase
multiple interactions
EXP ISO
vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein] vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in decreased activity of CAT protein]
CTD
PMID:26296324 PMID:33823243 PMID:37336463
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
CTD
PMID:36416909
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
vanillin results in decreased expression of CCN2 mRNA
CTD
PMID:17178418
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Clk2
CDC-like kinase 2
increases expression
ISO
vanillin results in increased expression of CLK2 mRNA
CTD
PMID:17178418
NCBI chr 3:89,072,102...89,084,394
Ensembl chr 3:89,072,102...89,084,228
G
Cst3
cystatin C
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased expression of CST3 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of CST3 protein]
CTD
PMID:29216766
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
G
Cxcl15
C-X-C motif chemokine ligand 15
increases expression multiple interactions
ISO
vanillin results in increased expression of CXCL8 mRNA vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]
CTD
PMID:20491607 PMID:21920952 PMID:36416909
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
vanillin results in increased expression of CYP1A1 mRNA
CTD
PMID:20491607
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
decreases activity multiple interactions
ISO
vanillin results in decreased activity of CYP2A6 protein [[vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin
CTD
PMID:32496054
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
vanillin results in increased expression of DDIT4 mRNA
CTD
PMID:17178418
NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
G
Dnmt3b
DNA methyltransferase 3B
decreases expression
ISO
vanillin results in decreased expression of DNMT3B mRNA
CTD
PMID:17178418
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
vanillin results in decreased expression of DUSP6 mRNA
CTD
PMID:17178418
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
G
Fasl
Fas ligand
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased expression of FASLG protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of FASLG protein]
CTD
PMID:29216766
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fbp1
fructose bisphosphatase 1
affects binding
ISO
vanillin binds to FBP1 protein
CTD
PMID:33823243
NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
vanillin results in decreased expression of FGFR2 mRNA
CTD
PMID:17178418
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Fzd2
frizzled class receptor 2
decreases expression
ISO
vanillin results in decreased expression of FZD2 mRNA
CTD
PMID:17178418
NCBI chr11:102,495,257...102,498,884
Ensembl chr11:102,495,222...102,498,884
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
affects binding
ISO
vanillin binds to G6PC1 protein
CTD
PMID:33823243
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein]
CTD
PMID:37336463
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GAPDH protein]
CTD
PMID:37336463
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
vanillin results in increased expression of GCLC mRNA
CTD
PMID:17178418
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
increases expression
ISO
vanillin results in increased expression of GCLM mRNA
CTD
PMID:17178418
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Glo1
glyoxalase 1
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GLO1 protein]
CTD
PMID:37336463
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
G
Gsr
glutathione reductase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]
CTD
PMID:37336463
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hmox1
heme oxygenase 1
increases expression
ISO
vanillin results in increased expression of HMOX1 mRNA
CTD
PMID:17178418
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
decreases mutagenesis
ISO
vanillin results in decreased mutagenesis of HPRT1 gene
CTD
PMID:17178418
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Hspa1b
heat shock protein 1B
increases expression
ISO
vanillin results in increased expression of HSPA1B mRNA
CTD
PMID:17178418
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
G
Il12b
interleukin 12b
multiple interactions
ISO
vanillin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]
CTD
PMID:36416909
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il18
interleukin 18
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased expression of IL18 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of IL18 protein]
CTD
PMID:29216766
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
multiple interactions
EXP
vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA]
CTD
PMID:26296324
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions
EXP
vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA]
CTD
PMID:26296324
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Insig1
insulin induced gene 1
decreases expression
ISO
vanillin results in decreased expression of INSIG1 mRNA
CTD
PMID:17178418
NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
G
Jund
jun D proto-oncogene
decreases expression
ISO
vanillin results in decreased expression of JUND mRNA
CTD
PMID:17178418
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Lcn2
lipocalin 2
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein]
CTD
PMID:29216766
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Map2k2
mitogen-activated protein kinase kinase 2
decreases expression
ISO
vanillin results in decreased expression of MAP2K2 mRNA
CTD
PMID:17178418
NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
G
Mark4
MAP/microtubule affinity regulating kinase 4
decreases expression
ISO
vanillin results in decreased expression of MARK4 mRNA
CTD
PMID:17178418
NCBI chr 7:19,159,027...19,193,255
Ensembl chr 7:19,158,700...19,192,746
G
Mt1
metallothionein 1
multiple interactions
EXP
vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA]
CTD
PMID:27074584
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt2
metallothionein 2
increases expression multiple interactions
ISO EXP
vanillin results in increased expression of MT2A mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA]
CTD
PMID:20491607 PMID:27074584
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of NOS2 protein]
CTD
PMID:29216766
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
decreases expression
ISO
vanillin results in decreased expression of PPP1R10 mRNA
CTD
PMID:17178418
NCBI chr17:36,227,404...36,243,175
Ensembl chr17:36,227,326...36,243,175
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA]
CTD
PMID:17465205 PMID:26296324
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Pygl
liver glycogen phosphorylase
affects binding
ISO
vanillin binds to PYGL protein
CTD
PMID:33823243
NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
vanillin inhibits the reaction [Cisplatin results in increased expression of RELA protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of RELA protein]
CTD
PMID:29216766
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Slc35d2
solute carrier family 35, member D2
decreases expression
ISO
vanillin results in decreased expression of SLC35D2 mRNA
CTD
PMID:17178418
NCBI chr13:64,244,122...64,277,195
Ensembl chr13:64,244,122...64,277,182
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
increases expression
ISO
vanillin results in increased expression of SLC7A11 mRNA
CTD
PMID:17178418
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
decreases expression
ISO
vanillin results in decreased expression of TGFB1I1 mRNA
CTD
PMID:17178418
NCBI chr 7:127,845,963...127,852,884
Ensembl chr 7:127,845,984...127,854,871
G
Tnf
tumor necrosis factor
multiple interactions
EXP ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein] vanillin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of TNF protein]
CTD
PMID:26296324 PMID:29216766 PMID:36416909
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trim16
tripartite motif-containing 16
increases expression
ISO
vanillin results in increased expression of TRIM16 mRNA
CTD
PMID:17178418
NCBI chr11:62,711,034...62,733,774
Ensembl chr11:62,711,057...62,741,634
G
Trp53
transformation related protein 53
decreases expression
ISO
vanillin results in decreased expression of TP53 mRNA
CTD
PMID:17178418
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
EXP
vanillin results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr11:73,158,315...73,191,194
Ensembl chr11:73,158,214...73,191,189
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
vanillin results in increased expression of UGP2 mRNA
CTD
PMID:17178418
NCBI chr11:21,271,126...21,321,267
Ensembl chr11:21,271,138...21,321,201
G
Ugt1a10
UDP glycosyltransferase 1 family, polypeptide A10
increases glucuronidation
ISO
UGT1A10 protein results in increased glucuronidation of vanillin
CTD
PMID:15117964
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of vanillin
CTD
PMID:15117964
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
22178
role
22194
application
21744
solvent
18197
formic acid
9159
formyl group
9120
aldehyde
9120
arenecarbaldehyde
146
1,3-Dimethyl-1H-pyrazole-4-carbaldehyde
0
1,3-thiazole-2-carbaldehyde +
0
1-Ethyl-1H-pyrrole-2-carboxaldehyde
0
1-Methyl-2-pyrrolecarboxaldehyde
0
1-acetylindole-3-carboxaldehyde
0
2,5-diformylfuran
0
2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde
0
2-(dihydroxymethyl)-5-formylfuran
0
4'-methyl-2,2'-bipyridine-4-carboxaldehyde
0
4-(phosphooxymethyl)-2-furancarboxaldehyde
0
4-Hydroxy-2,2'-bipyrrole-5-carbaldehyde
0
4-ethylpyrrole-2-carboxaldehyde
0
5-(\{5-[(5-(hydroxymethyl)furan-2-yl)methoxy(methoxymethyl)]furan-2-yl\}methoxy(methoxymethyl))furan-2-carbaldehyde
0
5-Methoxymethyl furfural
0
5-Sulfoxymethylfurfural
0
5-[(5-hydroxymethyl-furan-2-yl)methoxy-methoxymethyl]-furan-2-carbaldehyde
0
5-formyl-2-furoic acid
0
5-hydroxymethylfurfural
3
8-formyl-8-demethylriboflavin 5'-phosphate
0
Baldrinal
0
Ganoine
0
Irpexlacte B
0
Irpexlacte C
0
Jiangrine E
0
N-[4-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-butyl]-acetamide
0
N-[5-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-pentyl]-acetamide
0
Phlebopine A
0
Phlebopine B
0
Viburtinal
0
aromatic (S)-hydroxynitrile
0
benzaldehydes +
141
cyathusal A
0
cyathusal B
0
cyathusal C
0
demethylzeylasteral
0
grixazone A
0
kadsurenin M
0
mycobilin a
0
mycobilin b
0
naphthaldehydes +
1
oncrasin-1
1
piperonal
0
Path 2
CHEBI ontology
22178
subatomic particle
22170
composite particle
22170
hadron
22201
baryon
22170
nucleon
22170
atomic nucleus
22170
atom
22170
main group element atom
22104
p-block element atom
22104
carbon group element atom
21904
carbon atom
21859
organic molecular entity
21830
heteroorganic entity
21482
organochalcogen compound
20966
organooxygen compound
20806
carbon oxoacid
19593
carboxylic acid
19589
carboacyl group
18277
univalent carboacyl group
18277
formyl group
9120
aldehyde
9120
arenecarbaldehyde
146
1,3-Dimethyl-1H-pyrazole-4-carbaldehyde
0
1,3-thiazole-2-carbaldehyde +
0
1-Ethyl-1H-pyrrole-2-carboxaldehyde
0
1-Methyl-2-pyrrolecarboxaldehyde
0
1-acetylindole-3-carboxaldehyde
0
2,5-diformylfuran
0
2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde
0
2-(dihydroxymethyl)-5-formylfuran
0
4'-methyl-2,2'-bipyridine-4-carboxaldehyde
0
4-(phosphooxymethyl)-2-furancarboxaldehyde
0
4-Hydroxy-2,2'-bipyrrole-5-carbaldehyde
0
4-ethylpyrrole-2-carboxaldehyde
0
5-(\{5-[(5-(hydroxymethyl)furan-2-yl)methoxy(methoxymethyl)]furan-2-yl\}methoxy(methoxymethyl))furan-2-carbaldehyde
0
5-Methoxymethyl furfural
0
5-Sulfoxymethylfurfural
0
5-[(5-hydroxymethyl-furan-2-yl)methoxy-methoxymethyl]-furan-2-carbaldehyde
0
5-formyl-2-furoic acid
0
5-hydroxymethylfurfural
3
8-formyl-8-demethylriboflavin 5'-phosphate
0
Baldrinal
0
Ganoine
0
Irpexlacte B
0
Irpexlacte C
0
Jiangrine E
0
N-[4-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-butyl]-acetamide
0
N-[5-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-pentyl]-acetamide
0
Phlebopine A
0
Phlebopine B
0
Viburtinal
0
aromatic (S)-hydroxynitrile
0
benzaldehydes +
141
cyathusal A
0
cyathusal B
0
cyathusal C
0
demethylzeylasteral
0
grixazone A
0
kadsurenin M
0
mycobilin a
0
mycobilin b
0
naphthaldehydes +
1
oncrasin-1
1
piperonal
0